Moderna stock jumped on Investing.com on AI healthcare prospects

Investing.com — Modern Inc. (NASDAQ:) shares rose 14% on comments from Oracle (NYSE:) Chairman Larry Ellison about the potential of artificial intelligence (AI) to transform healthcare, especially early cancer detection and the development of personalized vaccines.

Ellison’s comments underscored the potential for early detection of cancer through blood tests and rapid development of individual vaccines to transform health care. Moderna’s stock boost comes as President Donald Trump announced a $500 billion private-sector investment in AI infrastructure, known as Stargate, a joint venture involving OpenAI, SoftBank ( TYO: ) and Oracle. This initiative is to strengthen its role in health care by establishing information centers and creating jobs.

The Oracle chairman explained how tumors circulating in the bloodstream can be detected using AI-powered blood tests that are finely divided, leading to early cancer diagnosis. Subsequently, AI may play a crucial role in gene sequencing of cancer tumors to develop personalized vaccines. These mRNA vaccines can be robotically produced within 48 hours, providing a rapid and personalized response to cancer treatment.

Although a specific analyst did not comment, the market’s response to Ellison’s vision and the significant private sector investment in AI infrastructure reflect the strong interest between healthcare and the technology. The jump in Moderna’s stock price reflects the company’s optimism surrounding this role in the future of AI-driven healthcare.

AI’s implications for healthcare, especially given Moderna’s expertise in mRNA technology, seem to be resonating with investors. As the industry shifts toward more personalized and efficient healthcare solutions, companies like Moderna can be at the forefront of these developments, leveraging investment and innovation in the field.

This article was created by AI Support and reviewed by an editor. See our T&C for more information.